(Q93196016)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

title

A novel specific PERK activator reduces toxicity and extends survival in Huntington's disease models (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

author name string

Talya Shacham

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Maria Kramer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Marina Shenkman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Hagit Eiger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Nitai Weinberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Ori Iancovici

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Somnath Roy

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Luba Simhaev

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Benny Da'adoosh

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Hamutal Engel

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Nisim Perets

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Yael Barhum

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Moshe Portnoy

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Daniel Offen

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

Gerardo Z Lederkremer

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

publication date

23 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

4 May 2020

page(s)

6875

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32327686%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

4 May 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC7181660/fullTextXML

inferred from PubMed Central ID database lookup

cites work

A polymorphic DNA marker genetically linked to Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Huntington disease: natural history, biomarkers and prospects for therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Therapeutic approaches to Huntington disease: from the bench to the clinic

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Rrs1 is involved in endoplasmic reticulum stress response in Huntington disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Impaired ERAD and ER stress are early and specific events in polyglutamine toxicity

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Endoplasmic reticulum stress: The cause and solution to Huntington's disease?

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Protein Misfolding and ER Stress in Huntington's Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Converging pathways in the occurrence of endoplasmic reticulum (ER) stress in Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

The unfolded protein response: from stress pathway to homeostatic regulation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Ligand-independent dimerization activates the stress response kinases IRE1 and PERK in the lumen of the endoplasmic reticulum.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

ER stress and the unfolded protein response

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Proteostasis control by the unfolded protein response

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

PERK activation mitigates tau pathology in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Dominant phenotypes produced by the HD mutation in STHdh(Q111) striatal cells

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Structural determinants of PERK inhibitor potency and selectivity

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (P

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Selective inhibition of a regulatory subunit of protein phosphatase 1 restores proteostasis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Autophagy and the integrated stress response

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Mouse models of Huntington's disease and methodological considerations for therapeutic trials

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Impaired motor speech performance in Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Selective neurodegeneration in Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Formation of polyglutamine inclusions in non-CNS tissue

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Increased frequency of diabetes mellitus in patients with Huntington's chorea

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Huntington's Disease and Diabetes: Chronological Sequence of its Association

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Atypical diabetes associated with inclusion formation in the R6/2 mouse model of Huntington's disease is not improved by treatment with hypoglycaemic agents.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

The R6/2 transgenic mouse model of Huntington's disease develops diabetes due to deficient beta-cell mass and exocytosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Target-Based Discovery of an Inhibitor of the Regulatory Phosphatase PPP1R15B

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Early Neurodegeneration in the Brain of a Child Without Functional PKR-like Endoplasmic Reticulum Kinase.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Tauopathy-associated PERK alleles are functional hypomorphs that increase neuronal vulnerability to ER stress

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Targeting PERK signaling with the small molecule GSK2606414 prevents neurodegeneration in a model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Comparative protein modelling by satisfaction of spatial restraints

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

1 reference

https://api.crossref.org/works/10.1038%2FS41598-020-63899-4

7 January 2021